Ultrasound-activated nano-TiO2 loaded with temozolomide paves the way for resection of chemoresistant glioblastoma multiforme
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-6966
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Ultrasound-activated nano-TiO2 loaded with temozolomide paves the way for resection of chemoresistant glioblastoma multiforme ; volume:12 ; number:1 ; day:10 ; month:7 ; year:2021 ; pages:1-17 ; date:12.2021
Cancer nanotechnology ; 12, Heft 1 (10.7.2021), 1-17, 12.2021
- Urheber
-
Rehman, Fawad Ur
Rauf, Mohd Ahmar
Ullah, Sajjad
Shaikh, Sana
Qambrani, Aqsa
Muhammad, Pir
Hanif, Sumaira
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12645-021-00088-6
- URN
-
urn:nbn:de:101:1-2021101620270122568054
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rehman, Fawad Ur
- Rauf, Mohd Ahmar
- Ullah, Sajjad
- Shaikh, Sana
- Qambrani, Aqsa
- Muhammad, Pir
- Hanif, Sumaira
- SpringerLink (Online service)
Ähnliche Objekte (12)
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme
Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme
Effects of chemotherapy with temozolomide on cell cycle associated proteins in glioblastoma multiforme
Patterns of failure for glioblastoma multiforme following limited-margin radiation and concurrent temozolomide
Concurrent bevacizumab and temozolomide alter the patterns of failure in radiation treatment of glioblastoma multiforme
AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme
Efficacy of systemic temozolomide‐activated phage‐targeted gene therapy in human glioblastoma
Glioblastoma multiforme-das Schicksal
Prognosefaktoren beim Glioblastoma multiforme
Bilateral cystic glioblastoma multiforme
Accelerated hyperfractionation plus temozolomide in glioblastoma
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme
Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme
Effects of chemotherapy with temozolomide on cell cycle associated proteins in glioblastoma multiforme
Patterns of failure for glioblastoma multiforme following limited-margin radiation and concurrent temozolomide
Concurrent bevacizumab and temozolomide alter the patterns of failure in radiation treatment of glioblastoma multiforme
AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme
Efficacy of systemic temozolomide‐activated phage‐targeted gene therapy in human glioblastoma
Glioblastoma multiforme-das Schicksal
Prognosefaktoren beim Glioblastoma multiforme
Bilateral cystic glioblastoma multiforme
Accelerated hyperfractionation plus temozolomide in glioblastoma
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme
Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme
Effects of chemotherapy with temozolomide on cell cycle associated proteins in glioblastoma multiforme
Patterns of failure for glioblastoma multiforme following limited-margin radiation and concurrent temozolomide
Concurrent bevacizumab and temozolomide alter the patterns of failure in radiation treatment of glioblastoma multiforme
AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme
Efficacy of systemic temozolomide‐activated phage‐targeted gene therapy in human glioblastoma
Glioblastoma multiforme-das Schicksal
Prognosefaktoren beim Glioblastoma multiforme
Bilateral cystic glioblastoma multiforme